On-Chip Electromembrane Surrounded Solid Phase Microextraction for Determination of Tricyclic Antidepressants from Biological Fluids Using Poly(3,4-ethylenedioxythiophene)-Graphene Oxide Nanocomposite as a Fiber Coating.
biological fluids
electromembrane extraction
electromembrane surrounded solid phase microextraction
human bone marrow aspirate
microfluidics
on-chip
poly(3,4-ethylenedioxythiophene)—graphene oxide
tricyclic antidepressants
Journal
Biosensors
ISSN: 2079-6374
Titre abrégé: Biosensors (Basel)
Pays: Switzerland
ID NLM: 101609191
Informations de publication
Date de publication:
14 Jan 2023
14 Jan 2023
Historique:
received:
20
11
2022
revised:
28
12
2022
accepted:
11
01
2023
entrez:
21
1
2023
pubmed:
22
1
2023
medline:
25
1
2023
Statut:
epublish
Résumé
In the present study, on-chip electromembrane surrounded solid phase microextraction (EM-SPME) was employed in the determination of tricyclic antidepressants (TCAs), including amitriptyline, nortriptyline, imipramine, desipramine, maprotiline, and sertraline, from various biological fluids. In this regard, poly(3,4-ethylenedioxythiophene)-graphene oxide (PEDOT-GO) was electrodeposited on an SPME fiber as a conductive coating, then the fiber played the acceptor-electrode role during the extraction. Thus, the immigration of the analytes under the influence of an electric field and their absorption onto the fiber coating were accomplished simultaneously. Under the optimized conditions, the limits of detection for the target analytes were acquired in the range of 0.005-0.025 µg L
Identifiants
pubmed: 36671973
pii: bios13010139
doi: 10.3390/bios13010139
pmc: PMC9856149
pii:
doi:
Substances chimiques
Antidepressive Agents, Tricyclic
0
poly(3,4-ethylene dioxythiophene)
0
Amitriptyline
1806D8D52K
Nortriptyline
BL03SY4LXB
Imipramine
OGG85SX4E4
graphene oxide
0
Desipramine
TG537D343B
Sertraline
QUC7NX6WMB
Maprotiline
2U1W68TROF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Molecules. 2021 May 22;26(11):
pubmed: 34067333
Postgrad Med. 2014 Mar;126(2):91-9
pubmed: 24685972
J Chromatogr A. 2016 Dec 2;1475:8-17
pubmed: 27836227
Mikrochim Acta. 2020 Jan 4;187(1):94
pubmed: 31902014
J Sep Sci. 2017 Nov;40(21):4222-4233
pubmed: 28837263
J Clin Lab Anal. 2012 Jul;26(4):286-94
pubmed: 22811363
J Chromatogr A. 2007 Dec 7;1174(1-2):104-11
pubmed: 17850807
J Affect Disord. 2013 Jan 10;144(1-2):7-15
pubmed: 22963896
J Chromatogr A. 2013 Mar 8;1280:16-22
pubmed: 23357753
J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3714-20
pubmed: 22035981
Chem Rev. 2018 Jul 25;118(14):6766-6843
pubmed: 29969244
Drugs. 2008;68(18):2611-32
pubmed: 19093703
Eur Neuropsychopharmacol. 2007 Jan 15;17(2):79-93
pubmed: 16904298
Endocr Metab Immune Disord Drug Targets. 2015;15(4):252-60
pubmed: 26100432
Anal Chim Acta. 2012 Aug 31;740:1-11
pubmed: 22840644
Front Neurol. 2017 Jul 14;8:307
pubmed: 28769859
J Sep Sci. 2020 Dec;43(23):4338-4346
pubmed: 32997397
Anal Chim Acta. 2012 May 6;725:51-6
pubmed: 22502611
ACS Appl Mater Interfaces. 2015 Oct 14;7(40):22137-47
pubmed: 26381462
Eur Child Adolesc Psychiatry. 2004;13 Suppl 1:I102-16
pubmed: 15322961
Pharmacogenomics. 2014 Jun;15(8):1147-57
pubmed: 25084207
J Am Chem Soc. 2008 May 7;130(18):5856-7
pubmed: 18399634
J Chromatogr A. 2015 May 29;1396:1-6
pubmed: 25907668
Br J Psychiatry. 2016 Mar;208(3):252-9
pubmed: 26541687
J Chromatogr A. 2006 Mar 24;1109(2):183-90
pubmed: 16445928
Dalton Trans. 2011 Nov 7;40(41):10945-52
pubmed: 21918761
J Sep Sci. 2019 Apr;42(8):1620-1628
pubmed: 30758140
Talanta. 2021 Mar 1;224:121864
pubmed: 33379075
Curr Treat Options Neurol. 2019 Mar 21;21(4):18
pubmed: 30895388
CMAJ. 2017 May 29;189(21):E747
pubmed: 28554948
N Engl J Med. 2014 Oct 30;371(18):1666-8
pubmed: 25354101
Electrophoresis. 2014 Sep;35(17):2421-8
pubmed: 24810105
Molecules. 2017 Jun 22;22(7):
pubmed: 28640203
J Psychosom Obstet Gynaecol. 2000 Dec;21(4):205-11
pubmed: 11191167